ES2052173T3 - Composiciones inyectables que contienen 25-cyclohexil-avermectina b1. - Google Patents

Composiciones inyectables que contienen 25-cyclohexil-avermectina b1.

Info

Publication number
ES2052173T3
ES2052173T3 ES90303716T ES90303716T ES2052173T3 ES 2052173 T3 ES2052173 T3 ES 2052173T3 ES 90303716 T ES90303716 T ES 90303716T ES 90303716 T ES90303716 T ES 90303716T ES 2052173 T3 ES2052173 T3 ES 2052173T3
Authority
ES
Spain
Prior art keywords
avermectin
cyclohexil
compositions containing
injectable compositions
parabitants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90303716T
Other languages
English (en)
Inventor
Stephen Richard Wicks
Edward Davison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898908071A external-priority patent/GB8908071D0/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of ES2052173T3 publication Critical patent/ES2052173T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)

Abstract

UNA SOLUCION DE AGENTES ANTIPARASITOS 25-CICLOHEXILO- AVERMECTINA B1 EN UN DISOLVENTE QUE CONTIENE DE 50 A 95% DE ACEITE DE SESAMO COMPLETADO CON ETILO OLEATO ES EFECTIVA CONTRA PARASITOS, TOLERANDOSE BIEN POR ANIMALES Y PUDIENDO SER INYECTADO UTILIZANDO EQUIPAMIENTOS DE INYECCION HABITUALES.
ES90303716T 1989-04-11 1990-04-06 Composiciones inyectables que contienen 25-cyclohexil-avermectina b1. Expired - Lifetime ES2052173T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898908071A GB8908071D0 (en) 1989-04-11 1989-04-11 Antiparasitic formulations
SG27894A SG27894G (en) 1989-04-11 1994-02-22 Injectable compositions containing 25-cyclohexyl-avermectin B1

Publications (1)

Publication Number Publication Date
ES2052173T3 true ES2052173T3 (es) 1994-07-01

Family

ID=26295191

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90303716T Expired - Lifetime ES2052173T3 (es) 1989-04-11 1990-04-06 Composiciones inyectables que contienen 25-cyclohexil-avermectina b1.

Country Status (16)

Country Link
EP (1) EP0393890B1 (es)
JP (1) JPH0647548B2 (es)
CN (1) CN1035356C (es)
AP (1) AP133A (es)
AU (1) AU609660B2 (es)
CY (1) CY1777A (es)
DK (1) DK0393890T3 (es)
EG (1) EG18956A (es)
ES (1) ES2052173T3 (es)
FI (1) FI92015C (es)
GR (1) GR3005794T3 (es)
HK (1) HK39294A (es)
NO (1) NO175882C (es)
OA (1) OA09203A (es)
RU (1) RU1836084C (es)
SG (1) SG27894G (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
CA2259469A1 (en) * 1996-06-05 1997-12-11 Ashmont Holdings Limited Injectable compositions
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
KR20000025762A (ko) * 1998-10-14 2000-05-06 유충식 이버멕틴류의 가용화 조성물
GB9827727D0 (en) 1998-12-16 1999-02-10 Pfizer Ltd Antiparasitic formulations
US20100022469A1 (en) * 2008-06-24 2010-01-28 Majid Razzak Anthelminthic formulations
JP2012517994A (ja) 2009-02-16 2012-08-09 ファイザー・インク 高投与量ドラメクチン製剤
EP2485725A2 (en) * 2009-10-07 2012-08-15 Wyeth LLC Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT396250B (de) * 1984-09-14 1993-07-26 American Cyanamid Co Verfahren zur herstellung von neuen antibiotisch wirkenden verbindungen
IL78621A (en) * 1985-04-30 1991-06-30 American Cyanamid Co Mylbemycin analogs,their preparation and pesticidal compositions containing them
US4707470A (en) * 1985-05-17 1987-11-17 Smithkline Beckman Corporation Polyene antibiotic emulsion formulation
EP0285561A3 (de) * 1987-03-27 1989-10-25 Ciba-Geigy Ag Parasitizide und insektizide Milbemycin-Derivate
CA1340771C (en) * 1987-11-09 1999-09-28 Shih-Jen Edward Lee Ethylated avermectins

Also Published As

Publication number Publication date
AP9000174A0 (en) 1990-04-30
DK0393890T3 (da) 1992-09-28
EP0393890B1 (en) 1992-08-12
JPH0647548B2 (ja) 1994-06-22
AU609660B2 (en) 1991-05-02
JPH02290820A (ja) 1990-11-30
NO175882B (no) 1994-09-19
CY1777A (en) 1995-10-20
EP0393890A1 (en) 1990-10-24
NO175882C (no) 1994-12-28
EG18956A (en) 1994-04-30
HK39294A (en) 1994-05-06
NO901637L (no) 1990-10-12
CN1046282A (zh) 1990-10-24
AP133A (en) 1991-06-05
AU5311990A (en) 1990-11-08
RU1836084C (ru) 1993-08-23
OA09203A (fr) 1992-06-30
CN1035356C (zh) 1997-07-09
GR3005794T3 (es) 1993-06-07
FI901816A0 (fi) 1990-04-10
NO901637D0 (no) 1990-04-10
SG27894G (en) 1995-03-17
FI92015B (fi) 1994-06-15
FI92015C (fi) 1994-09-26

Similar Documents

Publication Publication Date Title
MX9306499A (es) Composiciones farmaceuticas que contienen una anfetamina.
ES2175125T3 (es) Emulsionantes aceite/agua.
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
ES2136910T3 (es) Solucion de interferon.
AR240958A1 (es) Una composicion detergente acuosa que comrende un gel".
FI954963A (fi) Poly-1-n-alkeeniamiineja ja näitä sisältäviä poltto- ja voiteluainekoostumuksia
ES2124479T3 (es) Composiciones biocidas.
ES2060647T3 (es) Composicion blanqueante.
ES2114487B1 (es) Mezcla estabilizante sinergistica.
ES2140473T3 (es) Derivado fosfolipido y liposoma que lo contiene.
ES2185172T3 (es) Composiciones detergentes que comprenden una mannanasa y percarbonato.
FI932186A (fi) Detergentkompositioner
ES2072452T3 (es) Medios cosmeticos desodorizantes.
TR25422A (tr) Poliol poliesterler ve azalmtilmis kalorili trigliseritler iceren azaltilmis kalorili yag bilesimleri.
DE3872398D1 (de) Enzymatische waschmittelzusammensetzung.
DE69815549D1 (de) Pestizide zusammensetzung
ES2116279T3 (es) Composicion de caucho.
DE69529998D1 (de) Glp-1 zusammensetzungen mit verlängerter wirkdauer
DE68918561D1 (de) Bleichzusammensetzung.
ES2052173T3 (es) Composiciones inyectables que contienen 25-cyclohexil-avermectina b1.
ES2170158T3 (es) Composiciones topicas que contienen n-acetil-l-cisteina.
CO4600725A1 (es) Composiciones insecticidas sinergisticas
ES2045768T3 (es) Composiciones topicas que contienen defibrotida.
MX170928B (es) Composicion limpiadora para superficies duras
AR246103A1 (es) Mezclas azeotropicas de 1,1-dicloro-2,2,2-trifluoroetano y 1,1-dicloro-1-fluoroetano.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 393890

Country of ref document: ES